PycnoCentella: a new research-based combination ingredient for atherosclerosis (part II)

Published: 7-Oct-2025

Part II of this article explores how PycnoCentella, a novel combination of Pycnogenol and Centellicum, prevents and stabilises atherosclerotic plaques while supporting cardiovascular health with potent antioxidant and anti-inflammatory mechanisms

You need to be a subscriber to read this article.
Click here to find out more.

In addition to the previously mentioned direct benefits regarding atherosclerosis (see Part I), PycnoCentella also has potent antioxidant properties.

Oxidative stress was observed to be linked to atherosclerotic plaque progression via reactive oxygen species and the generation of oxidised LDL (low-density lipoprotein) cholesterol.16

In several studies, oxidative stress was assessed by measuring free radicals in the plasma before and after PycnoCentella supplementation.

Oxidative stress was reduced by 15% to 21% in the blood of patients with atherosclerosis after 3 months to 4 years of supplementation.5–12  

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.

Subscribe now Already a subscriber? Sign in here.

You may also like